SYMFI (efavirenz, lamivudine and tenofovir disoproxil fumarate) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 5, 2018 Category: Drugs & Pharmacology Source Type: news

Therapeutic Insect Allergen Extracts (Therapeutic Insect Allergen Extracts) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 5, 2018 Category: Drugs & Pharmacology Source Type: news

Asmanex Twisthaler (Mometasone Furoate Inhalation Powder) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 5, 2018 Category: Drugs & Pharmacology Source Type: news

Celiac Disease in Later Life Must Not Be Missed Celiac Disease in Later Life Must Not Be Missed
Celiac disease may manifest at any age. How prevalent is it in older persons, and how might symptoms present?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Antares Pharma Provides Xyosted Regulatory Update
EWING, N.J., April 05, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today announced that the U.S. Food and Drug Administration (FDA or the Agency) acknowledged receipt of the Company ’s March 29, 2018 resubmission to... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 5, 2018 Category: Drugs & Pharmacology Source Type: news

Antares Pharma Provides Xyosted (testosterone enanthate subcutaneous injection) Regulatory Update
EWING, N.J., April 05, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today announced that the U.S. Food and Drug Administration (FDA or the Agency) acknowledged receipt of the Company ’s March 29, 2018 resubmission to... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 5, 2018 Category: Drugs & Pharmacology Source Type: news

Diclofenac Sodium Extended Release Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 4, 2018 Category: Drugs & Pharmacology Source Type: news

Paratek ’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA
BOSTON, April 04, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Applications (NDAs) and granted a priority review for omadacycline, an... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 4, 2018 Category: Drugs & Pharmacology Source Type: news

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations
April 4, 2018 - Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted the company ’s New Drug Application and granted priority review for dacomitinib, a pan-human epidermal growth factor receptor (EGFR) tyrosine... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 4, 2018 Category: Drugs & Pharmacology Source Type: news

Alexander A. Vinks, PharmD, PhD, FCP, Director, Division of Clinical...
NDA Partners Chairman Carl Peck, MD announced today that Alexander (Sander) A. Vinks, PharmD, PhD, FCP, a prominent pediatric clinical pharmacology and clinical trials expert, has joined the firm as...(PRWeb April 04, 2018)Read the full story at http://www.prweb.com/releases/2018/03/prweb15374079.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 4, 2018 Category: Pharmaceuticals Source Type: news

US FDA Accepts Biologics License Application for Moxetumomab Pasudotox in Hairy Cell Leukemia
April 3, 2018 AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for moxetumomab pasudotox, an... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 3, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Bydureon (exenatide extended-release) for Use with Basal Insulin in Patients with Type 2 Diabetes with Inadequate Glycemic Control
April 3, 2018 AstraZeneca today announced the US Food and Drug Administration (FDA) has approved Bydureon (exenatide extended-release) for injectable suspension as an add-on therapy to basal insulin in adults with type 2 diabetes (T2D) with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 3, 2018 Category: Drugs & Pharmacology Source Type: news

IFN-free Chronic HCV Therapy With DAAs and Risk for HCC IFN-free Chronic HCV Therapy With DAAs and Risk for HCC
Does IFN-free therapy with direct-acting antivirals alter the short-term risk for hepatocellular carcinoma in patients with cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 3, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Alkermes Receives Refusal to File Letter From FDA for ALKS 5461
DUBLIN, April 2, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it received a Refusal to File letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ALKS 5461, a once-daily, oral... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 2, 2018 Category: Drugs & Pharmacology Source Type: news

Synflorix cost saving compared with Prevenar in New  Zealand
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Lumen-apposing metal stent cost  effective for pancreatic WON
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Caregiver costs for US patients with CVD predicted to double
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Dextrose gel in neonatal hypoglycaemia ticks all the boxes
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Healthcare burden of TGCTs substantial in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Rifapentine + isoniazid − cost effective for TB prevention?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Drug use in neonates varies between NICUs in the Netherlands
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Pneumococcal vaccine cost  effective in older adults
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Continued glucose monitoring cost  effective for T1DM
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Insulin pumps not cost  effective if no clinical need
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Drug companies give donations to patient groups in USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Australian PBS addition to reduce HIV transmission
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

India plans to launch public-funded health insurance scheme
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Intervention to increase VMMC uptake worth extra cost
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

ICER report on CAR-T therapies highlights cost issues
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Capped low co-payment reduces medicine usage
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

MDC in CKD good value for money in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Brexit expected to impact drug  costs and HTA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Diabetes − enormous burden on society in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

WSG has no impact on short-term healthcare costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Biomarker testing in NSCLC: better survival, acceptable extra cost
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

EBV treatment cost  effective for severe emphysema
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

BRCA testing in early breast cancer cost  effective in Malaysia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Danish Medicines Agency issues 3 new reimbursement guidelines
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

NHS England freeing up funds for frontline care
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

New drugs added to Australian PBS
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Allopurinol/lesinurad cost effective for gout/hyperuricaemia
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Prescription drug-related morbidity and mortality costly in USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

UK: calls to end the deadlock on cystic fibrosis drug
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

GDP measures consumption, but misses social progress
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Does I-CBT for paediatric chronic pain reduce healthcare costs?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

RPS response to NHS England guidance on over the counter medicines
Responding to NHS Englandguidance published todayon over the counter items that should not routinely be prescribed in primary care, RPS English Pharmacy Board Chair Sandra Gidley said:“All p (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 29, 2018 Category: Drugs & Pharmacology Source Type: news

We are now closed until Tuesday 3rd April
Our offices are now closed and will reopen on 3rd April 2018 at 9am. We wish everyone a Happy Easter! (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 29, 2018 Category: Drugs & Pharmacology Source Type: news

Changes to governance documents
At the meeting held on 22nd March 2018, RPS Assembly agreed a number of significant amendments to the Society’s Regulations that will take effect from 8th June. Please see full details at How We (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 29, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Expands Approval of Blincyto (blinatumomab) to Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
March 29, 2018 -- The U.S. Food and Drug Administration granted accelerated approval to Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) who are in remission but still have minimal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 29, 2018 Category: Drugs & Pharmacology Source Type: news

Medical Device Alert: All T34 ambulatory syringe pumps
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Medical Device Alert for all T34 ambulatory syringe pumps, due to a risk of unintended pump shutdown and delay to treatment. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 29, 2018 Category: Drugs & Pharmacology Source Type: news